Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 69.27 Million EUR | 283.08% |
| 2022 | 18.08 Million EUR | -76.35% |
| 2021 | 76.45 Million EUR | 19.23% |
| 2020 | 64.12 Million EUR | 30.94% |
| 2019 | 48.97 Million EUR | 13.4% |
| 2018 | 43.18 Million EUR | 1510.85% |
| 2017 | 2.68 Million EUR | -74.23% |
| 2016 | 10.4 Million EUR | 558.77% |
| 2015 | 1.57 Million EUR | 0.25% |
| 2014 | 1.57 Million EUR | -36.44% |
| 2013 | 2.47 Million EUR | -26.1% |
| 2012 | 3.35 Million EUR | 11.25% |
| 2011 | 3.01 Million EUR | -32.53% |
| 2010 | 4.46 Million EUR | -34.11% |
| 2009 | 6.77 Million EUR | -32.39% |
| 2008 | 10.02 Million EUR | -41.34% |
| 2007 | 17.09 Million EUR | 9.44% |
| 2006 | 15.61 Million EUR | 155.81% |
| 2005 | 6.1 Million EUR | -16.71% |
| 2004 | 7.33 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 53 Million EUR | 0.0% |
| 2024 Q1 | 53 Million EUR | -23.49% |
| 2023 Q3 | 65.93 Million EUR | -3.39% |
| 2023 FY | 69.27 Million EUR | 283.08% |
| 2023 Q4 | 69.27 Million EUR | 5.06% |
| 2023 Q1 | 65.44 Million EUR | 261.93% |
| 2023 Q2 | 68.25 Million EUR | 4.29% |
| 2022 FY | 18.08 Million EUR | -76.35% |
| 2022 Q4 | 18.08 Million EUR | -71.71% |
| 2022 Q3 | 63.92 Million EUR | -11.36% |
| 2022 Q2 | 72.11 Million EUR | -6.93% |
| 2022 Q1 | 77.48 Million EUR | 1.34% |
| 2021 Q3 | 84.06 Million EUR | 30.99% |
| 2021 Q1 | 67.26 Million EUR | 4.9% |
| 2021 Q2 | 64.17 Million EUR | -4.6% |
| 2021 Q4 | 76.45 Million EUR | -9.04% |
| 2021 FY | 76.45 Million EUR | 19.23% |
| 2020 Q4 | 64.12 Million EUR | -10.7% |
| 2020 FY | 64.12 Million EUR | 30.94% |
| 2020 Q2 | 74.21 Million EUR | -6.24% |
| 2020 Q1 | 79.15 Million EUR | 61.63% |
| 2020 Q3 | 71.81 Million EUR | -3.23% |
| 2019 Q3 | 57.47 Million EUR | 10.71% |
| 2019 FY | 48.97 Million EUR | 13.4% |
| 2019 Q4 | 48.97 Million EUR | -14.79% |
| 2019 Q2 | 51.91 Million EUR | -3.81% |
| 2019 Q1 | 53.97 Million EUR | 24.97% |
| 2018 Q3 | 43.18 Million EUR | 3.64% |
| 2018 FY | 43.18 Million EUR | 1510.85% |
| 2018 Q2 | 41.67 Million EUR | 0.23% |
| 2018 Q4 | 43.18 Million EUR | -0.0% |
| 2018 Q1 | 41.57 Million EUR | 1450.73% |
| 2017 FY | 2.68 Million EUR | -74.23% |
| 2017 Q4 | 2.68 Million EUR | -84.12% |
| 2017 Q3 | 16.87 Million EUR | 7.41% |
| 2017 Q2 | 15.71 Million EUR | 0.0% |
| 2017 Q1 | 15.71 Million EUR | 51.06% |
| 2016 Q4 | 10.4 Million EUR | 0.0% |
| 2016 FY | 10.4 Million EUR | 558.77% |
| 2016 Q1 | 4.96 Million EUR | 214.31% |
| 2016 Q2 | 4.96 Million EUR | 0.02% |
| 2016 Q3 | 10.4 Million EUR | 109.55% |
| 2015 Q1 | 1.49 Million EUR | -5.4% |
| 2015 FY | 1.57 Million EUR | 0.25% |
| 2015 Q2 | 1.49 Million EUR | 0.0% |
| 2015 Q3 | 1.58 Million EUR | 6.11% |
| 2015 Q4 | 1.57 Million EUR | -0.13% |
| 2014 Q3 | 1.57 Million EUR | 8.02% |
| 2014 Q1 | 1.45 Million EUR | -41.2% |
| 2014 Q2 | 1.45 Million EUR | 0.07% |
| 2014 FY | 1.57 Million EUR | -36.44% |
| 2014 Q4 | 1.57 Million EUR | 0.0% |
| 2013 Q2 | 6.51 Million EUR | -0.02% |
| 2013 Q4 | 2.47 Million EUR | 0.0% |
| 2013 Q3 | 2.47 Million EUR | -61.94% |
| 2013 FY | 2.47 Million EUR | -26.1% |
| 2013 Q1 | 6.51 Million EUR | 94.18% |
| 2012 Q4 | 3.35 Million EUR | 0.0% |
| 2012 Q2 | 1.53 Million EUR | 0.0% |
| 2012 FY | 3.35 Million EUR | 11.25% |
| 2011 Q2 | 25.77 Million EUR | 0.0% |
| 2011 Q4 | 3.01 Million EUR | 0.0% |
| 2011 FY | 3.01 Million EUR | -32.53% |
| 2010 Q2 | 27.14 Million EUR | 0.0% |
| 2010 FY | 4.46 Million EUR | -34.11% |
| 2010 Q4 | 4.46 Million EUR | 0.0% |
| 2009 FY | 6.77 Million EUR | -32.39% |
| 2009 Q4 | 6.77 Million EUR | 0.0% |
| 2008 FY | 10.02 Million EUR | -41.34% |
| 2007 FY | 17.09 Million EUR | 9.44% |
| 2006 FY | 15.61 Million EUR | 155.81% |
| 2005 FY | 6.1 Million EUR | -16.71% |
| 2004 FY | 7.33 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Cegedim SA | 285.1 Million EUR | 75.702% |
| Guerbet SA | 364.58 Million EUR | 81.0% |
| Nexus AG | 20.24 Million EUR | -242.173% |
| Bastide Le Confort Médical SA | 356.96 Million EUR | 80.594% |
| Revenio Group Oyj | 18.7 Million EUR | -270.444% |
| Drägerwerk AG & Co. KGaA | 471.38 Million EUR | 85.304% |
| Sartorius Aktiengesellschaft | 5.27 Billion EUR | 98.688% |
| LNA Santé SA | 887.67 Million EUR | 92.196% |
| Siemens Healthineers AG | 633 Million EUR | 89.056% |
| Medios AG | 17.14 Million EUR | -303.971% |
| Stratec SE | 141.37 Million EUR | 50.999% |